This EASL Deep Dive explores key updates from the EASL Clinical Practice Guidelines on hepatocellular carcinoma (HCC), with a practical focus on diagnosis and treatment selection. Experts will discuss evolving imaging and diagnostic criteria, patient selection for surgery and locoregional therapies, and how to adapt management according to response to systemic treatment. The session will also highlight the growing importance of multidisciplinary, individualised care across the HCC treatment pathway.
Podden och tillhörande omslagsbild på den här sidan tillhör
European Association for the Study of the Liver (EASL). Innehållet i podden är skapat av European Association for the Study of the Liver (EASL) och inte av,
eller tillsammans med, Poddtoppen.